Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
There has been a lot of clamor over the introduction of Wegovy for weight loss. The GLP-1 mimetic had such a huge introduction that supply was not able to keep up with demand. This is a double strength Ozempic product and looks to help patients with obesity as well as …
Read More »From the Editor
August, 2021
Latest Articles
August, 2021
-
7 August
Greater Weight Loss Found With SGLT-2 Inhibitors Than GLP-1 RAs in Patients with T2D
Contrary to previous studies, new research finds SGLT-2i more effective for weight loss than GLP-1 RAs as add-on therapy to Metformin.
Read More » -
7 August
How Does Sleep Duration Affect Gestational Diabetes Risk?
The prevalence of gestational diabetes may be related to the duration of sleep among pregnant women.
Read More » -
7 August
ADA 2021: Dasiglucagon and the Effects Among Various Demographics
Dasiglucagon is a glucagon analog stable in an aqueous formulation with FDA approval for severe hypoglycemia use. The target population is patients with diabetes who are six years of age and older, but how effective is it among other subgroups?
Read More » -
3 August
Dosing Error Due to Misinterpretation
When reviewing the medical record of a hospital patient before meeting with her for a diabetes consult, I noted that the doctor had ordered 46 units of Lantus to be given daily at bedtime....
Read More » -
3 August
Here We Go Again: The Low-Carb vs. High-Carb and Training Debate
By Sheri Colberg, PhD
Read More »
Who knew I'd be talking about carbohydrate intake and being active for the third time this year, but here we go again! Unfortunately, a lot of confusion still exists related to the practice known as "carb loading" as well. Do you need to do it? Should you? How do you know?
More Articles
August, 2021
-
3 August
Semglee, a Biosimilar Insulin to Glargine, Receives FDA Approval
With the introduction of this new biosimilar insulin, patients with diabetes will have the opportunity to have easier and broader access to insulin therapy, and a more affordable option than those already on the market.
Read More » -
3 August
ADA 81st Symposium: The Onset of T2D in Youth and Long-Term Complications
Pediatric patients with T2D have accelerated onset of hypertension, dyslipidemia, kidney disease, nerve disease, and diabetic retinopathy.
Read More »
July, 2021
-
31 July
Does Cycling Increase the Lifespan of People Living with Type 2 Diabetes?
Recently completed research examines the effect of consistent cycling on all-cause and cardiovascular mortality.
Read More » -
31 July
Can a Low-Carb Diet Reverse T2D?
Investigating whether a low-carb diet can lead to diabetes remission.
Read More » -
31 July
Mental Health and COVID-19
Physical activity is linked to mental health; how has the pandemic affected exercise options and mental well-being?
Read More » -
27 July
Gestational Diabetes Can Increase CVD Risk
GD history is linked with coronary artery calcification (CAC) in women, an indicator of atherosclerotic CVD, and a predictor of CVD clinical events.
Read More » -
27 July
ADA 81st Symposium: Effect of Dietary Carbohydrate Restriction on Health-Related Quality of Life and Cognition
We know the positive effects of carbohydrate restriction on glycemia, but what is the impact on quality of life and cognition?
Read More » -
27 July
ADA 81st Symposium: COVID-19 and New-Onset Type 2 Diabetes
How has the pandemic affected the incidence of type 2 diabetes and other conditions such as Hyperosmolar Hyperglycemic Syndrome (HHS) within the younger population?
Read More » -
24 July
ADA 81st Symposium: Cardiovascular and Kidney Outcomes in Efpeglenatide
With the introduction of this glucagon-like peptide-1 receptor agonist (GLP-1 RA), efpeglenatide, could we see new cardiovascular and renal benefits for patients with type 2 diabetes?
Read More » -
24 July
How are Diabetes and Cardiovascular Disease Related?
Major electrocardiogram abnormalities have been found in patients with type 2 diabetes.
Read More »